Experimental Silicone Vaginal Ring To Be Tested As Female-Controlled HIV, Herpes Prevention Tool, Researchers Report

International Business Times: Silicone vaginal rings protect women against herpes and HIV
“…According to researchers from the University Jean Monnet of Saint-Etienne in France, the [silicone vaginal] ring can deliver hydrophilic molecules such as tenofovir, which is active on HIV-1, and acyclovir, which is active on the herpes virus. … The new silicone vaginal rings … are intended to be evaluated in clinical trials, with plans of producing them commercially at high rate and low cost. Their research was presented at the 55th Inter-Science Conference on Antimicrobial Agents and Chemotherapy” (Tecsan, 9/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.